Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Provencio M"'
Autor:
Fernández-Miranda I; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., Pedrosa L; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., González-Rincón J; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain; CoE Data Intelligence, Fujitsu Technology Solutions S.A., Pozuelo de Alarcón, Madrid, Spain., Espinet B; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain; Department of Pathology, Hospital del Mar, Barcelona, Spain., de la Cruz Vicente F; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Seville, Spain., Climent F; Department of Pathology, Hospital Universitari de Bellvitge-IDIBELL, Barcelona, Spain., Gómez S; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., Royuela A; Biostatistics Unit, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA. CIBERESP, ISCIII. Madrid, Spain., Camacho FI; Department of Pathology, Hospital Universitario de Getafe, Madrid, Spain., Martín-Acosta P; Department of Pathology, Cancer Molecular Pathology Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., Yanguas-Casás N; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain; Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain., Domínguez M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., Méndez M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain; Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., Colomo L; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain., Salar A; Department of Hematology, Hospital del Mar, Barcelona, Spain., Horcajo B; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., Navarro M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., García-Cosío M; Department of Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Piris-Villaespesa M; Department of Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Llanos M; Department of Oncology, Hospital Universitario de Canarias, Tenerife, Spain., García JF; Department of Pathology, Hospital MD Anderson Cancer Center, Madrid, Spain., Sequero S; Department of Oncology, Hospital Universitario San Cecilio, Granada, Spain., Mercadal S; Department of Hematology, ICO-Hospital Duran I Reynals, Barcelona, Spain., García-Hernández S; Department of Pathology, Hospital Universitario de Canarias, Tenerife, Spain., Navarro B; Department of Hematology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain., Mollejo M; Department of Pathology, Complejo Hospitalario de Toledo, Spain., Provencio M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain; Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Facultad de Medicina, Universidad Autónoma de Madrid, IDIPHISA, Madrid, Spain., Sánchez-Beato M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain. Electronic address: msbeato@idiphim.org.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Jul; Vol. 37 (7), pp. 100516. Date of Electronic Publication: 2024 May 17.
Autor:
Gumà J; Medical Oncology Department, Hospital Universitari Sant Joan de Reus, IISPV, URV, Reus, Tarragona, Spain. josep.guma@salutsantjoan.cat., Palazón-Carrión N; Medical Oncology Department, Hospital Universitario Virgen de la Macarena, Seville, Spain., Rueda-Domínguez A; UGCI Medical Oncology, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain., Sequero S; Medical Oncology Department, Hospital Universitario San Cecilio, Granada, Spain., Calvo V; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain., García-Arroyo R; Medical Oncology Department, Complejo Hospitalario Universitario, Pontevedra, Spain., Gómez-Codina J; Medical Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Llanos M; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Martínez-Banaclocha N; Oncology Department, Hospital General Universitario Dr. Balmis, Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Sep; Vol. 25 (9), pp. 2749-2758. Date of Electronic Publication: 2023 Jun 08.
Autor:
Baptista MJ; Department of Hematology, ICO-Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain., Tapia G; Department of Pathology, Hospital Germans Trias i Pujol, IGTP, Universitat Autònoma de Barcelona, Badalona, Spain., Muñoz-Marmol AM; Department of Pathology, Hospital Germans Trias i Pujol, IGTP, Universitat Autònoma de Barcelona, Badalona, Spain., Muncunill J; Department of Hematology, ICO-Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain., Garcia O; Department of Hematology, ICO-Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain., Montoto S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Gribben JG; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Calaminici M; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Martinez A; Department of Pathology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain., Veloza L; Department of Pathology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain., Martínez-Trillos A; Department of Hematology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain., Aldamiz T; Department of Infectious Diseases, Hospital Gregorio Marañón, Madrid, Spain., Menarguez J; Department of Pathology, Hospital Gregorio Marañón, Madrid, Spain., Terol MJ; Department of Hematology and Oncology, Hospital Clínic Universitari de València, Valencia, Spain., Ferrandez A; Department of Pathology, Hospital Clínic Universitari de València, Valencia, Spain., Alcoceba M; Department of Hematology, Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC and Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain., Briones J; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain., González-Barca E; Department of Hematology, ICO-Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain., Climent F; Department of Pathology, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Badalona, Spain., Muntañola A; Department of Clinical Hematology, Hospital Universitari Mutua de Terrassa, Terrassa, Spain., Moraleda JM; Department of Hematology, Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain., Provencio M; Department of Medical Oncology, Hospital Universitario Puerta De Hierro, Majadahonda, Spain., Abrisqueta P; Department of Hematology, Hospital Vall d'Hebrón, Barcelona, Spain., Abella E; Department of Hematology, Hospital del Mar, Barcelona, Spain., Colomo L; Department of Pathology, Hospital del Mar, Barcelona, Spain., García-Ballesteros C; Department of Hematology, Hospital Arnau de Vilanova, Valencia, Spain., Garcia-Caro M; Department of Hematology, Hospital de Mataro, Barcelona, Spain., Sancho JM; Department of Hematology, ICO-Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain., Ribera JM; Department of Hematology, ICO-Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain., Mate JL; Department of Pathology, Hospital Germans Trias i Pujol, IGTP, Universitat Autònoma de Barcelona, Badalona, Spain., Navarro JT; Department of Hematology, ICO-Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain.
Publikováno v:
Histopathology [Histopathology] 2022 Dec; Vol. 81 (6), pp. 826-840. Date of Electronic Publication: 2022 Oct 04.
Autor:
Jiménez-Cortegana C; Medical Biochemistry and Molecular Biology and Immunology, Virgen Macarena University Hospital, Sevilla, Seville, Spain., Palazón-Carrión N, Martin Garcia-Sancho A; Hematology Dept, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain., Nogales-Fernandez E; Clinical Oncology Dept. Medicine Department, University of Seville, Virgen Macarena University Hospital, Seville, Spain., Carnicero-González F; Hematology Dept, San Pedro de Alcántara Hospital, Cáceres, Spain., Ríos-Herranz E; Hematology Dept, Virgen de Valme University Hospital, Seville, Spain., de la Cruz-Vicente F; Hematology Dept, Virgen del Rocío University Hospital, Seville, Spain., Rodríguez-García G; Hematology Dept, Virgen del Rocío University Hospital, Seville, Spain., Fernández-Álvarez R; Hematology Dept, Cabueñes Hospital, Gijón, Spain., Rueda Dominguez A; Hematology/ClinicalOncology Dept, Costa del Sol Hospital, Marbella, Málaga, Spain., Casanova-Espinosa M; Hematology/ClinicalOncology Dept, Costa del Sol Hospital, Marbella, Málaga, Spain., Martínez-Banaclocha N; Clinical Oncology Dept, Alicante General University Hospital, Alicante, Spain., Gumà-Padrò J; Clinical Oncology Dept, Sant Joan de Reus University Hospital URV, IISPV, Reus, Spain., Gómez-Codina J; Clinical Oncology Dept, La Fé University Hospital, Valencia, Spain., Labrador J; Hematology Dept, Hospital Universitario de Burgos, Burgos, Spain., Salar-Silvestre A; Hematology Dept, Hospital del Mar, Barcelona, Spain., Rodriguez-Abreu D; Clinical Oncology Dept, Insular University Hospital, Las Palmas de Gran Canaria, Spain., Galvez-Carvajal L; Unidad de Gestión Clínica Intercentros de Oncología Médica de Málaga, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain., Provencio M; Clinical Oncology Dept, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain., Sánchez-Beato M; Lymphoma Research Group, Clinical Oncology Dept, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain., Guirado-Risueño M; Clinical Oncology Dept, Elche General University Hospital General, Elche, Alicante, Spain., Espejo-García P; Clinical Oncology Dept. Medicine Department, University of Seville, Virgen Macarena University Hospital, Seville, Spain., Lejeune M; Pathology Department, Plataforma de Estudios Histológicos, Citológicos y de Digitalización, Hospital de Tortosa Verge de la Cinta, IISPV, URV, Tortosa, Tarragona, Spain., Álvaro T; Pathology Dept, Hospital de Tortosa Verge de la Cinta, Catalan Institute of Health, Institut d'Investigació Sanitària Pere Virgili (IISPV), Tortosa, Tarragona, Spain., Sánchez-Margalet V; Medical Biochemistry and Molecular Biology and Immunology, Virgen Macarena University Hospital, Sevilla, Seville, Spain margalet@us.es ldelacruzmerino@gmail.com., de la Cruz-Merino L
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jun; Vol. 9 (6).
Autor:
Pedrosa L; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain.; PhD Program in Molecular Biosciences, Doctoral School, Universidad Autónoma de Madrid, Madrid, Spain., Fernández-Miranda I; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain.; PhD Program in Molecular Biosciences, Doctoral School, Universidad Autónoma de Madrid, Madrid, Spain., Pérez-Callejo D; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.; PhD Program in Medicine and Surgery, Doctoral School, Universidad Autónoma de Madrid, Madrid, Spain., Quero C; Medical Oncology Department, Hospital Universitario Virgen de La Victoria, Malaga, Spain., Rodríguez M; Pathology Department, Hospital Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Martín-Acosta P; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Molecular Pathology Laboratory, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain., Gómez S; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain., González-Rincón J; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Santos A; Molecular Pathology Laboratory, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain., Tarin C; Bioinformatics Unit, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Basic Medical Sciences, Faculty of Medicine, Universidad CEU San Pablo, Madrid, Spain., García JF; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Pathology Department, MD Anderson Cancer Center, Madrid, Spain., García-Arroyo FR; Medical Oncology Department, Complejo Hospitalario de Pontevedra, Pontevedra, Spain., Rueda A; Medical Oncology Department, Hospitales Universitarios Regional y Virgen de La Victoria, IBIMA, Malaga, Spain., Camacho FI; Pathology Department, Hospital Universitario de Getafe, Madrid, Spain., García-Cosío M; Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Heredero A; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain., Llanos M; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Mollejo M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Pathology Department, Complejo Hospitalario de Toledo, Toledo, Spain., Piris-Villaespesa M; Haematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Gómez-Codina J; Medical Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Yanguas-Casás N; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain., Sánchez A; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Piris MA; Pathology Department, Hospital Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Sánchez-Beato M; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain. msbeato@idiphim.org.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. msbeato@idiphim.org.
Publikováno v:
Scientific reports [Sci Rep] 2021 Jan 21; Vol. 11 (1), pp. 1886. Date of Electronic Publication: 2021 Jan 21.
Autor:
Baptista MJ; a Department of Hematology , ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona , Badalona , Spain., Tapia G; b Department of Pathology , Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona , Badalona , Spain., Morgades M; a Department of Hematology , ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona , Badalona , Spain., Muncunill J; a Department of Hematology , ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona , Badalona , Spain., Muñoz-Marmol AM; b Department of Pathology , Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona , Badalona , Spain., Montoto S; c Centre for Haemato-Oncology, Barts Cancer Institute , Queen Mary University of London , London , United Kingdom., Gribben JG; c Centre for Haemato-Oncology, Barts Cancer Institute , Queen Mary University of London , London , United Kingdom., Calaminici M; c Centre for Haemato-Oncology, Barts Cancer Institute , Queen Mary University of London , London , United Kingdom., Martinez A; d Department of Pathology , Hospital Clinic, IDIBAPS, University of Barcelona , Barcelona , Spain., Gonzalez-Farre B; d Department of Pathology , Hospital Clinic, IDIBAPS, University of Barcelona , Barcelona , Spain., Dlouhy I; e Department of Hematology , Hospital Clinic, IDIBAPS, University of Barcelona , Barcelona , Spain., González-Barca E; f Department of Hematology , ICO-Hospital Duran i Reynals , L'Hospitalet de Llobregat , Spain., Terol MJ; g Department of Hematology and Oncology , Hospital Clínic Universitari de València , Valencia , Spain., Miralles P; h Department of Infectious Diseases , Hospital Gregorio Marañón , Madrid , Spain., Alcoceba M; i Department of Hematology , Hospital Universitario de Salamanca , Salamanca , Spain., Vall-Llovera F; j Department of Clinical Hematology , Hospital Universitari Mutúa de Terrassa , Terrassa , Spain., Briones J; k Department of Hematology , Hospital de la Santa Creu i Sant Pau, Josep Carreras Leukaemia Research Institute (IJC) , Barcelona , Spain., Abrisqueta P; l Department of Hematology , Hospital Vall d'Hebrón , Barcelona , Spain., Abella E; m Department of Hematology , Hospital del Mar , Barcelona , Spain., Provencio M; n Department of Medical Oncology , Hospital Universitario Puerta De Hierro , Majadahonda , Spain., García-Ballesteros C; o Department of Hematology , Hospital Arnau de Vilanova , Valencia , Spain., Moraleda JM; p Department of Hematology , Hospital Clinico Universitario Virgen de la Arrixaca , Murcia , Spain., Sancho JM; a Department of Hematology , ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona , Badalona , Spain., Ribera JM; a Department of Hematology , ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona , Badalona , Spain., Mate JL; b Department of Pathology , Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona , Badalona , Spain., Navarro JT; a Department of Hematology , ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona , Badalona , Spain.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2019 Apr; Vol. 60 (4), pp. 1087-1091. Date of Electronic Publication: 2018 Oct 15.
Autor:
González-Rincón J; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain., Méndez M; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Gómez S; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain., García JF; Pathology Department, Hospital MD Anderson Cancer Center, Madrid, Spain., Martín P; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain.; Pathology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Bellas C; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain.; Pathology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Pedrosa L; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain., Rodríguez-Pinilla SM; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain.; Pathology Department, Fundación Jiménez Díaz, Madrid, Spain., Camacho FI; Pathology Department, Hospital Universitario de Getafe, Madrid, Spain., Quero C; Medical Oncology Department, Hospital Universitario Virgen de la Victoria, Malaga, Spain., Pérez-Callejo D; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Rueda A; Medical Oncology Department, Hospital Costa del Sol, Malaga, Spain., Llanos M; Medical Oncology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Gómez-Codina J; Medical Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Piris MA; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain.; Pathology Department, Fundación Jiménez Díaz, Madrid, Spain., Montes-Moreno S; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain.; Pathology Department/Translational Hematology Group, Hospital Universitario Marqués de Valdecilla/IDIVAL, Santander, Spain., Bárcena C; Pathology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Rodríguez-Abreu D; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canarias, Spain., Menárguez J; Pathology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., de la Cruz-Merino L; Medical Oncology Department Hospital Universitario Virgen Macarena, Seville, Spain., Monsalvo S; Hematology Department, Fundación Jiménez Díaz, Madrid, Spain., Parejo C; TIC Unit- Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro- Segovia de Arana, Madrid, Spain., Royuela A; Clinical Biostatistics Unit, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain., Kwee I; Institute of Oncology Research (IOR), Belinzona, Switzerland.; Universitá della Svizzera Italiana (USI), Lugano, Switzerland.; Dalle Molle Institute for Artificial Intelligence (IDSIA), Belinzona, Switzerland.; Swiss Institute of Bioinformatics (SIB), Belinzona, Switzerland., Cascione L; Institute of Oncology Research (IOR), Belinzona, Switzerland.; Universitá della Svizzera Italiana (USI), Lugano, Switzerland.; Swiss Institute of Bioinformatics (SIB), Belinzona, Switzerland.; Oncology Institute of Southern Switzerland (IOSI), Belinzona, Switzerland., Arribas A; Institute of Oncology Research (IOR), Belinzona, Switzerland.; Universitá della Svizzera Italiana (USI), Lugano, Switzerland.; Swiss Institute of Bioinformatics (SIB), Belinzona, Switzerland.; Oncology Institute of Southern Switzerland (IOSI), Belinzona, Switzerland., Bertoni F; Institute of Oncology Research (IOR), Belinzona, Switzerland.; Universitá della Svizzera Italiana (USI), Lugano, Switzerland.; Swiss Institute of Bioinformatics (SIB), Belinzona, Switzerland.; Oncology Institute of Southern Switzerland (IOSI), Belinzona, Switzerland., Mollejo M; Pathology Department, Hospital Virgen de la Salud, Toledo, Spain., Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Sánchez-Beato M; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.
Publikováno v:
PloS one [PLoS One] 2019 Feb 25; Vol. 14 (2), pp. e0212813. Date of Electronic Publication: 2019 Feb 25 (Print Publication: 2019).
Autor:
Rubio J; Medical Oncology Service, Onco-Hematology Research Unit, Instituto de Investigación Sanitaria Puerta de Hierro, Hospital Universitario Puerta de Hierro-Majadahonda , Madrid , Spain., Franco F, Sánchez A, Cantos B, Méndez M, Calvo V, Maximiano C, Perez D, Millán I, Sánchez-Beato M, Provencio M
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2015 Jun; Vol. 56 (6), pp. 1686-90. Date of Electronic Publication: 2014 Nov 20.
Autor:
Montes-Moreno S; Pathology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain GELTAMO Group, Spanish Society of Hematology, Santander, Spain smontes@humv.es., Batlle A; Department of Hematology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., de Villambrosía SG; GELTAMO Group, Spanish Society of Hematology, Santander, Spain Department of Hematology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Sánchez-Espiridión B; Grupo de Genómica del Cáncer, IDIVAL, Santander, Spain., Cereceda L; Grupo de Genómica del Cáncer, IDIVAL, Santander, Spain., González-Barca E; GELTAMO Group, Spanish Society of Hematology, Santander, Spain Servicio de Hematología Clínica, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain., Purroy N; PETHEMA, Programa Español de tratamientos en Hematología, L'Hospitalet de Llobregat, Barcelona, Spain Department of Hematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Pardal E; GELTAMO Group, Spanish Society of Hematology, Santander, Spain Department of Hematology, Hospital Virgen del PuertoPlasencia, Salamanca, Spain., Martín A; GELTAMO Group, Spanish Society of Hematology, Santander, Spain Department of Hematology, Hospital Universitario de Salamanca/IBSAL, Salamanca, Spain., Grande C; GELTAMO Group, Spanish Society of Hematology, Santander, Spain Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain., Mazorra F; Pathology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Insunza A; GELTAMO Group, Spanish Society of Hematology, Santander, Spain., Quero C; GOTEL (Grupo Oncológico para el Tratamiento de las Enfermedades Linfoides), L'Hospitalet de Llobregat, Barcelona, Spain Oncology Department, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain., Aguiar D; GOTEL (Grupo Oncológico para el Tratamiento de las Enfermedades Linfoides), L'Hospitalet de Llobregat, Barcelona, Spain Oncology Department, Hospital Universitario de Gran Canaria, Dr Negrín, Gran Canaria, Spain., Cruz MA; GOTEL (Grupo Oncológico para el Tratamiento de las Enfermedades Linfoides), L'Hospitalet de Llobregat, Barcelona, Spain Oncology Department, Hospital Virgen de la Salud, Toledo, Spain., Rueda A; GOTEL (Grupo Oncológico para el Tratamiento de las Enfermedades Linfoides), L'Hospitalet de Llobregat, Barcelona, Spain Oncology Department, Hospital Costa del Sol, Marbella, Spain., Llanos M; GOTEL (Grupo Oncológico para el Tratamiento de las Enfermedades Linfoides), L'Hospitalet de Llobregat, Barcelona, Spain Oncology Department, Hospital Universitario de Canarias, La Laguna, Spain., Codina JG; GOTEL (Grupo Oncológico para el Tratamiento de las Enfermedades Linfoides), L'Hospitalet de Llobregat, Barcelona, Spain Oncology Department, Hospital La Fe, Valencia, Spain., Arroyo FR; GOTEL (Grupo Oncológico para el Tratamiento de las Enfermedades Linfoides), L'Hospitalet de Llobregat, Barcelona, Spain Oncology Department, Hospital de Pontevedra, Madrid, Spain., Caballero D; GELTAMO Group, Spanish Society of Hematology, Santander, Spain Department of Hematology, Hospital Universitario de Salamanca/IBSAL, Salamanca, Spain., Conde E; GELTAMO Group, Spanish Society of Hematology, Santander, Spain Department of Hematology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., López A; PETHEMA, Programa Español de tratamientos en Hematología, L'Hospitalet de Llobregat, Barcelona, Spain Department of Hematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Provencio M; GOTEL (Grupo Oncológico para el Tratamiento de las Enfermedades Linfoides), L'Hospitalet de Llobregat, Barcelona, Spain Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Piris M; Pathology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
Publikováno v:
Haematologica [Haematologica] 2014 Aug; Vol. 99 (8), pp. e138-41. Date of Electronic Publication: 2014 Apr 24.
Autor:
Bellas C; Laboratory of Molecular Pathology, Instituto de Investigación Sanitaria, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., García D; Laboratory of Molecular Pathology, Instituto de Investigación Sanitaria, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Vicente Y; Laboratory of Molecular Pathology, Instituto de Investigación Sanitaria, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Kilany L; Laboratory of Molecular Pathology, Instituto de Investigación Sanitaria, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Abraira V; Unidad de Bioestadística Clínica, Hospital Universitario Ramón y Cajal, CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Navarro B; Department of Hematology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Provencio M; Medical Oncology Service, Onco-hematology Research Unit, Instituto de Investigación Sanitaria, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Martín P; Laboratory of Molecular Pathology, Instituto de Investigación Sanitaria, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Publikováno v:
PloS one [PLoS One] 2014 Jun 02; Vol. 9 (6), pp. e98169. Date of Electronic Publication: 2014 Jun 02 (Print Publication: 2014).